Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in human cell types
See how this story connectsGoogle DeepMind announced AlphaGenome 2, a conditional model that predicts how a DNA sequence and its variants act in one chosen cell type, tissue or state at a time. It was trained on more than 100 million individual cell profiles across 68 tissues. On the TenK10K dataset of 28 primary immune cell types, it identified 30% of causal variants against 16% for the original AlphaGenome fine-tuned on single-cell data, and 43% of directional gene effects against 23%.
Why it matters
Non-commercial researchers can use AlphaGenome 2 through its API today, commercial research is in private preview, and it is not validated for clinical or diagnostic use.
- When
- 11 Nov 2026
- ID
WTA-N-2026-0851- Where
- International
- Who
- Google DeepMind
- Topics
- Biology, Model releases
Summary written with AI by wheresthe.ai, from Google DeepMind. Checked against the source on 11 Nov 2026.
Source copy: saved on 11 Nov 2026 to check this story and not republished, because the text belongs to its publisher. Also held by the Internet Archive.
Cite this story
WTA-N-2026-0851: “Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in human cell types.” wheresthe.ai, 11 Nov 2026. https://wheresthe.ai/d/intl-deepmind-alphagenome-2-cell-type-dna-model-2026-11/ (source: Google DeepMind).
Spotted an error? Email [email protected].